BASF Environmental Catalyst and Metal Solutions inaugure un nouvel investissement dans l’hydrogène vert à Budenheim, en Allemagne

La nouvelle installation produira des composants pour l’électrolyse et les piles à combustible afin de soutenir la transition énergétique mondiale La production devrait commencer à l’été 2025 Investissement conjoint avec d’autres partenaires BUDENHEIM, Allemagne, 11 juill. 2024 (GLOBE NEWSWIRE) — BASF Environmental Catalyst and Metal Solutions (ECMS) a entamé la construction de sa première installation de […]

Continue Reading

BASF Environmental Catalyst and Metal Solutions breaks ground on new green hydrogen investment in Budenheim, Germany

Groundbreaking of new green hydrogen production facility in Budenheim, Germany Pictured left to right: Dr. Günter Krummel, Gesellschafter Trigona FCC; André Semann, CFO Budenheim; Meaghan McGuire, Head of Strategic Marketing, Hydrogen, BASF ECMS; Tim Ingle, SVP Precious Metal Services and Recycling, BASF ECMS; Saeed Alerasool, SVP R&D and Application, BASF ECMS; Daniel Malko, Head of […]

Continue Reading

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Continue Reading